Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
|---|---|---|---|---|---|
| RO2-M52H3 | Mouse | Mouse ROR2 / NTRKR2 Protein, His Tag (MALS verified) |  |
|
|
| RO2-H82E3 | Human | Biotinylated Human ROR2 / NTRKR2 Protein, His,Avitag™ |  |
|
|
| RO2-M5253 | Mouse | Mouse ROR2 / NTRKR2 Protein, Fc Tag |  |
|
|
| RO2-H52E5 | Human | Human ROR2 / NTRKR2 Protein, His Tag |  |
|
|
| RO2-H5251 | Human | Human ROR2 / NTRKR2 Protein, Fc Tag |  |
|
Immobilized Human ROR2, His Tag (Cat. No. RO2-H52E5) at 1 μg/mL (100 μL/well) can bind Anti-ROR2 Antibody, Human IgG1 with a linear range of 0.1-4 ng/mL (QC tested).
The purity of Mouse ROR2 Protein, His Tag (Cat. No. RO2-M52H3) is more than 85% and the molecular weight of this protein is around 45-65 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| CCT301-59 | CCT301-59 | Phase 2 Clinical | Bioatla, F1 Oncology | Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Sarcoma | Details |
| Ozuriftamab Vedotin | CAB-ROR2; CAB-ROR2-ADC; CAB-ADC; BA-3021; HTBA-3021 | Phase 2 Clinical | Bioatla | Ovarian Neoplasms; Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
| CCT301-59 | CCT301-59 | Phase 2 Clinical | Bioatla, F1 Oncology | Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Sarcoma | Details |
| Ozuriftamab Vedotin | CAB-ROR2; CAB-ROR2-ADC; CAB-ADC; BA-3021; HTBA-3021 | Phase 2 Clinical | Bioatla | Ovarian Neoplasms; Solid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
This web search service is supported by Google Inc.
A-Z
